Rhythm Pharmaceuticals (RYTM) Times Interest Earned (2022 - 2025)
Rhythm Pharmaceuticals (RYTM) has disclosed Times Interest Earned for 4 consecutive years, with -$10.2 as the latest value for Q4 2025.
- On a quarterly basis, Times Interest Earned fell 34.64% to -$10.2 in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.33, a 27.61% increase, with the full-year FY2025 number at -$9.33, up 27.61% from a year prior.
- Times Interest Earned was -$10.2 for Q4 2025 at Rhythm Pharmaceuticals, up from -$11.1 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$7.57 in Q3 2024 to a low of -$29.42 in Q1 2024.
- A 4-year average of -$12.67 and a median of -$10.65 in 2025 define the central range for Times Interest Earned.
- Peak YoY movement for Times Interest Earned: crashed 71.43% in 2024, then surged 70.46% in 2025.
- Rhythm Pharmaceuticals' Times Interest Earned stood at -$13.98 in 2022, then skyrocketed by 35.14% to -$9.07 in 2023, then increased by 16.49% to -$7.57 in 2024, then crashed by 34.64% to -$10.2 in 2025.
- Per Business Quant, the three most recent readings for RYTM's Times Interest Earned are -$10.2 (Q4 2025), -$11.1 (Q3 2025), and -$7.79 (Q2 2025).